Should surgery or chemotherapy come first in patients with epithelial ovarian cancer? It depends… Robert DeBernardo, MD, discusses a recent outcomes study, emphasizing the importance early diagnosis and referral to centers of excellence.
Flipping the Research Paradigm for Rare Uterine Cancers
Cleveland Clinic Ob/Gyn & Women’s Health Institute receives $2 million gift to establish first endowed chair for uterine cancer research.
Anesthesia Considerations in HIPEC for Epithelial Ovarian Cancer
HIPEC improves survival, though careful intraoperative management is key. Robert DeBernardo, MD, explains the results of a HIPEC study presented at the Society for Gynecologic Oncology’s Annual Meeting.
HoloLens to Assess the Resectability of Ovarian Cancer
Feasibility study will determine how augmented reality assessment compares to the current model of minimally invasive evaluation and the standard-of-care conventional surgery for ovarian cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
How Sentinel Lymph Node Detection Is Improving Care for Endometrial Cancer Patients
When endometrial cancer is diagnosed, accurate staging and treatment techniques optimize patient outcomes. Learn how minimally invasive staging is improving accuracy while reducing complications.